Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 29, 2026 | $1.24 | +17.0% | $5.30B | +5.8% | $1.04 |
| Q1 FY26ended Mar 31, 2026 | May 6, 2026 | $0.85 | −30.9% | $5.13B | +7.4% | $1.05 |
| Q4 FY25ended Dec 31, 2025 | — | $1.29 | −17.8% | $5.70B | +7.1% | — |
| Q3 FY25ended Sep 30, 2025 | — | $0.98 | −3.9% | $5.14B | +5.8% | — |
| Q2 FY25ended Jun 30, 2025 | — | $1.06 | +14.0% | $5.01B | +3.5% | — |
| Q1 FY25ended Mar 31, 2025 | — | $1.23 | +51.9% | $4.78B | +2.7% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.57 | +78.4% | $5.32B | +2.2% | — |
| Q3 FY24ended Sep 30, 2024 | — | $1.02 | +24.4% | $4.86B | +0.9% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe GE HealthCare Technologies shares, not any token. As of Jul 29, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $0.93 | — | $4.84B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.81 | — | $4.65B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.88 | — | $5.21B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.82 | — | $4.82B | — | — |